Sanofi

Multinational Pharma Share Declines in Indian Drug Market. (Image Source: Freepik)

Pharma MNCs continue to lose India market share

The presence of multinational pharma companies (MNCs) in India’s drug market continues to shrink, reaching 14.5% in May 2025 from…

June 8, 2025 18:27 IST

dividend stocks, stock split, April 2025 corporate actions, CRISIL dividend,

Upcoming dividend announcement, stock split this week: Watch out for these 5 stocks

Watch for dividends, stock splits from CRISIL, Hexaware, Kapil Raj, and more this week. Hold stocks before ex-dates for payouts.

Updated: April 14, 2025 15:04 IST

USFDA approves novel treatment for Hemophilia; Medication can be given up to once every 2 months

Qfitlia does not replace the missing clotting factor. Rather, it reduces the amount of a protein called antithrombin, leading to…

March 30, 2025 11:43 IST

Sanofi to increase competition in atopic dermatitis market after Dupixent’s success

The collaboration between Sanofi and Kymera Therapeutics on SAR444656 may represent a significant opportunity for competition in atopic dermatitis treatment.

January 19, 2025 15:41 IST

Sanofi’s Multiple sclerosis drug misses goal in trials for relapsing disease forms

On Monday, Sanofi only provided a brief summary of the trials, holding off details for a medical conference in Copenhagen…

September 2, 2024 16:28 IST

Sanofi resets footprint in India, Hyd GCC to add new digital competencies

On the investments made, a note shared by the company said, there were plans to invest in all €400 million…

July 17, 2024 17:34 IST

French drugmaker Sanofi to invest over €1 billion in production sites

Sanofi to expand its Global Capacity Centre in Hyderabad

The Hyderabad hub has grown exponentially from being a Medical Hub to now providing several best-in-class services to Sanofi’s global…

July 17, 2024 16:40 IST

Rare diseases, rare diseases in India, Sanofi, Sanofi India, sanofi specialty care, healthcare news, pharma news,

We are moving into newer disease areas; Xenpozyme will be launched in India soon: Anil Raina, GM, Sanofi Specialty Care, India

The French drugmakers have launched groundbreaking medicines for Gaucher disease, Pompe disease, Fabry disease, mucopolysaccharidosis I (MPS I) and acid…

May 30, 2024 16:07 IST

French drugmaker Sanofi to invest over €1 billion in production sites

Sanofi will invest an additional €700 million per year in R&D over the next two years. In 2023, Sanofi invested…

May 14, 2024 10:58 IST

Sanofi launches its anti-diabetic drug in India—Know cost and other key details

According to the company, Soliqua is a once-daily injectable combination drug containing insulin glargine 100 Units/ml, which is a long-acting…

May 1, 2024 11:01 IST

Sanofi’s new polio vaccine gets nod in India amid speculations of potential shortage

Sanofi and Serum Institute of India are the leading suppliers of IPV vaccines in India.

April 8, 2024 11:12 IST

French drugmaker Sanofi agrees to settle 4,000 Zantac cancer lawsuits in US state courts

Sanofi now sells Zantac360, a reformulated heartburn medicine whose active ingredient is famotidine.

April 4, 2024 12:38 IST

Sanofi India and Cipla's shares rose today

Sanofi to launch key drugs from its global pipeline in India soon

The company is also looking at widening access through partnerships with companies like Cipla, Dr Reddy’s Laboratories, and Emcure.

April 2, 2024 10:42 IST

Dr Reddy’s to distribute Sanofi’s paediatric and adult vaccine brands in India

The partnership with Sanofi gives Dr. Reddy’s a strong portfolio and major presence in the vaccine segment taking it to…

March 27, 2024 17:59 IST

Sanofi India, Cipla, partnership, distribution, CNS portfolio, anti-epileptic medication, production, manufacturing, healthcare

Sanofi, Cipla enters into exclusive distribution partnership to expand reach of CNS portfolio in India

While Sanofi India will continue to own, import, and manufacture its complete range of CNS products across plants in India…

March 27, 2024 09:33 IST

Sanofi, rare disease portfolio, sanofi product portfolio, healthcare news, pharma news,

Sanofi drops rare disease drug purchase after FTC files suit

Sanofi owns the only FDA approved treatments — a biweekly infusion — but Maze is developing a daily oral medication…

December 12, 2023 16:47 IST

Sanofi taps adviser for OTC spinoff as buyout firms circle

The business has also attracted some initial interest from major buyout firms that have been evaluating a potential acquisition

November 16, 2023 15:02 IST

Sanofi spinoff EuroAPI’s shares plunge on sales surprise

Sanofi still owns 30% of EuroAPI and the French state has a 12% stake, reflecting government efforts to bolster national…

October 10, 2023 16:24 IST

Related News

Aadhaar rule change 2025: New UIDAI update fees, PAN-Aadhaar link and KYC rules explained

Big Aadhaar update from November 2025: No document upload needed — UIDAI to verify details automatically

Asia Cup Trophy Controversy: India refuses award, PCB proposes special handover

Asia Cup 2025 Trophy row: PCB chief Mohsin Naqvi sends firm message to BCCI, says ‘If you want the trophy, we…’

39-year-old Mehul Goswami has been accused of 'stealing' more than $50,000 in taxpayer money by working for a contractor while on the clock for his state job. (Photo: Pexels)

Indian-origin NY resident arrested in US for working two jobs, faces 15 years in jail

Techie discusses move back to India amid Green Card concerns.

Techie plans return to India after 15 years in US amid green card uncertainty, says ‘want to move before…’

F-1 visa denied for applicant after single question at US Consulate

‘Benchmark yield seen easing to 6.15% within three months,’ Sandeep Yadav, DSP Mutual Fund

Money6 hr ago

Sandeep Yadav, head of fixed income at DSP Mutual Fund, predicts that the Reserve Bank of India’s accommodative stance, potential trade deal with the US, and reduced fiscal concerns will lead to a decrease in government bond yields. He advises investors to consider gilt funds to benefit from this trend.

View all shorts